These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32757419)

  • 1. High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study.
    Poncet-Megemont L; Paris P; Tronchere A; Salazard JP; Pereira B; Dallel R; Aumeran C; Beytout J; Jacomet C; Laurichesse H; Lesens O; Mrozek N; Vidal M; Moisset X
    Headache; 2020 Nov; 60(10):2578-2582. PubMed ID: 32757419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.
    Rocha-Filho PAS; Magalhães JE
    Cephalalgia; 2020 Nov; 40(13):1443-1451. PubMed ID: 33146035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentations, systemic inflammation response and ANDC scores in hospitalized patients with COVID-19.
    Hsu JL; Liu MC; Tsau PW; Chung FT; Lin SM; Chen ML; Ro LS
    Sci Rep; 2024 Sep; 14(1):22480. PubMed ID: 39341876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
    Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
    Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-discharge persistent headache and smell or taste dysfunction after hospitalisation for COVID-19: a single-centre study.
    Akıncı T
    Ir J Med Sci; 2023 Feb; 192(1):369-375. PubMed ID: 35304709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
    Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological features and outcome in COVID-19: dementia can predict severe disease.
    Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS
    J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
    Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.
    Membrilla JA; de Lorenzo Í; Sastre M; Díaz de Terán J
    Headache; 2020 Nov; 60(10):2176-2191. PubMed ID: 32989732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.
    Faycal A; Ndoadoumgue AL; Sellem B; Blanc C; Dudoit Y; Schneider L; Tubiana R; Valantin MA; Seang S; Palich R; Bleibtreu A; Monsel G; Godefroy N; Itani O; Paccoud O; Pourcher V; Caumes E; Ktorza N; Chermak A; Abdi B; Assoumou L; Katlama C;
    Infect Dis Now; 2022 Mar; 52(2):75-81. PubMed ID: 34800742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache characteristics in COVID-19 pandemic-a survey study.
    Uygun Ö; Ertaş M; Ekizoğlu E; Bolay H; Özge A; Kocasoy Orhan E; Çağatay AA; Baykan B
    J Headache Pain; 2020 Oct; 21(1):121. PubMed ID: 33050880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Anosmia in 10.157 Pediatric COVID-19 Cases: Multicenter Study from Turkey.
    Elvan-Tuz A; Karadag-Oncel E; Kiran S; Kanik-Yuksek S; Gulhan B; Hacimustafaoglu M; Ozdem-Alatas S; Kuyucu N; Ozdemir H; Egil O; Elmas-Bozdemir S; Polat M; Bursal-Duramaz B; Cem E; Apaydin G; Teksam O;
    Pediatr Infect Dis J; 2022 Jun; 41(6):473-477. PubMed ID: 35349499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
    D'Souza G; Springer G; Gustafson D; Kassaye S; Alcaide ML; Ramirez C; Sharma A; Palella FJ; Tien PC; Detels R; Kempf MC; Lahiri CD; Rinaldo CR; French AL; Margolick JB; Adimora AA
    HIV Res Clin Pract; 2020 Oct; 21(5):130-139. PubMed ID: 33211636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of new or more severe headaches following COVID-19 is associated with markers of microglial activation and peripheral sensitization: results from a prospective cohort study.
    Ruhnau J; Blücher M; Bahlmann S; Zieme A; Vogelgesang A; Steinmetz A; Fleischmann R
    J Headache Pain; 2024 Jun; 25(1):101. PubMed ID: 38890625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness.
    Blair JE; Gotimukul A; Wang F; Mina SA; Bartels HC; Burns MW; Kole AE; Vikram HR; Gea-Banacloche JC; Seville MT; Petty SAB; Vikram A; Orenstein R
    Medicine (Baltimore); 2021 Jun; 100(24):e26371. PubMed ID: 34128896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.